Blockade of CD47 mediated CTSS-PAR2 signaling provides a therapeutic target for hepatocellular carcinoma
Page 1 of 1
Blockade of CD47 mediated CTSS-PAR2 signaling provides a therapeutic target for hepatocellular carcinoma
Lee TKW, Cheung VCH, Lu P, Lau EYT, Ma S, Tang KH, Tong M, Lo J, Ng IOL. Blockade of CD47 mediated CTSS-PAR2 signaling provides a therapeutic target for hepatocellular carcinoma. Hepatology. 2014;[Epub ahead of print] doi:10.1002/hep.27070
Last edited by Jon Moulton on Thu Feb 13, 2014 11:36 am; edited 1 time in total (Reason for editing : Fix URL)
Similar topics
» miRNA-487a Promotes Proliferation and Metastasis in Hepatocellular Carcinoma
» Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features
» Blockade of CD47 increases survival of mice exposed to lethal total body irradiation
» Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression
» Thrombospondin-1 Regulates Blood Flow via CD47 Receptor–Mediated Activation of NADPH Oxidase 1
» Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features
» Blockade of CD47 increases survival of mice exposed to lethal total body irradiation
» Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression
» Thrombospondin-1 Regulates Blood Flow via CD47 Receptor–Mediated Activation of NADPH Oxidase 1
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum